New Hope is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Reliv International Introduces Slimplicity® in the Philippines

Reliv International Inc., has launched the Slimplicity(r) Weight Loss System in the Philippines.

The Slimplicity Weight Loss System is comprised of a meal replacement product and Accelerator capsules. In combination with a healthy diet and exercise, the meal replacement and capsules are designed to help individuals manage their weight.

The Philippines is the first Reliv market in Asia to sell Slimplicity. Reliv plans to begin selling the Slimplicity Weight Loss System in the company's other Asian markets -- Malaysia, Singapore and Brunei. Slimplicity will replace Reliv Ultrim-Plus(r), also a weight-management product, which is still sold in the other Asian countries.

Reliv has gradually rolled out Slimplicity to its international markets following its U.S. introduction in 2007. In Australia and New Zealand, the product is known as Slimsimply.

About Reliv

Reliv International, Inc., based in Chesterfield, Mo., is a developer, manufacturer and marketer of a proprietary line of nutritional supplements. Reliv supplements address essential daily nutrition, weight loss and targeted solutions such as energy and performance enhancement, digestive health, women's health and anti-aging. Reliv sells its products through an international network marketing system of approximately 68,680 independent distributors. Additional information about Reliv International, Inc. can be obtained on the Web at

This news release was distributed by GlobeNewswire,

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.